Functional Fluidics (https://www.functionalfluidics.com/) recently participated in a pivotal study that indicates their biomarkers of red blood cell health can help define and predict acute pain crises in individuals with Sickle Cell Disease (SCD). This addresses a tremendous need for well-validated biomarkers to objectively monitor red blood cell health in individuals with sickle cell disease.
top of page
Search
Recent Posts
See AllBy: Steven Loeb Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times...
Matterworks, Inc., developers of the world's most powerful metabolomics platform, which accelerates the discovery, development, and...
Luna, the leading provider of in-home physical therapy, has teamed up with UCI Health, to expand access to patient care by providing...
bottom of page
Comentários